DOVER, Del.--(BUSINESS WIRE)--Telehealth company Henry Meds, known for its innovation in telehealth medicine and commitment to patient-centric care, announced today that it will now provide healthcare to patients suffering with symptoms associated with menopause and perimenopause.

“Our patients will benefit from our personalized care, expertise, experience, and the growing amounts of scientific data showing a clear benefit from hormone replacement therapy to provide relief from the daily and long-term impacts of menopause and perimenopause,” said Dr. Steven Peacock, Chief Medical Officer, Henry Meds. “As leaders in the telehealth field, Henry Meds healthcare providers meet virtually with each patient to understand their symptoms and concerns, provide complimentary testing if appropriate and help determine the best therapeutic approach for each individual patient.”